Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression

Journal of International Medical Research

Volumn 39, Issue 6, 2011, Pages 2119-2128

  Geng, Y J ^a   Xie, S L ^a   Li, Q ^b   Ma, J ^a   Wang, G Y ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b Hospital of Stomatology Jilin University   (China)

Author keywords

Gene expression; Hepatocellular carcinoma; HOTAIR; Large intervening non coding RNAs; Lymph node metastasis; Matrix metalloproteinase 9; Vascular endothelial growth factor

Indexed keywords

GELATINASE B; LARGE INTERVENING NON CODING RNA; TUMOR MARKER; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VASCULOTROPIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HOX TRANSCRIPT ANTISENSE RNA GENE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ONCOGENE; PROGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 84555208731     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900608     Document Type: Article

References (38)

1. Parkin DM, Bray F, Ferlay J, et al: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156.
2. Jemal A, Bray F, Center, MM, et al: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750.
4. Taylor-Robinson SD, Foster GR, Arora S, et al: Increase in primary liver cancer in the UK, 1979-94. Lancet 1997; 350: 1142-1143.
5. Jemal A, Siegel R, Xu J, et al: Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
6. Tang ZY: Hepatocellular carcinoma surgery: review of the past and prospects for the 21st century. J Surg Oncol 2005; 91: 95-96.
7. Hao K, Luk JM, Lee NP, et al: Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer 2009; 9: 389.
8. Bertone P, Stolc V, Royce TE, et al: Global identification of human transcribed sequences with genome tiling arrays. Science 2004; 306: 2242-2246.
9. Amaral PP, Dinger ME, Mercer TR, et al: The eukaryotic genome as an RNA machine. Science 2008; 319: 1787-1789.
10. Guttman M, Amit I, Garber M, et al: Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009; 458: 223-227.
11. Feng J, Bi C, Clark BS, et al: The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev 2006; 20: 1470-1484.
12. Wang X, Arai S, Song X, et al: Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008; 454: 126-130.
13. Sunwoo H, Dinger ME, Wilusz JE, et al: MEN ε/β nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Res 2009; 19: 347-359.
14. Yu W, Gius D, Onyango P, et al: Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 2008; 451: 202-206.
15. Song X, Wang B, Bromberg M, et al: Retroviral-mediated transmission of a mouse VL30 RNA to human melanoma cells promotes metastasis in an immunodeficient mouse model. Proc Natl Acad Sci U S A 2002; 99: 6269-6273.
16. Wang F, Li X, Xie X, et al: UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 2008; 582: 1919-1927.
17. Rinn JL, Kertesz M, Wang JK, et al: Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129: 1311-1323.
18. Tsai MC, Manor O, Wan Y, et al: Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010; 329: 689-693.
19. Gupta RA, Shah N, Wang KC, et al: Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-1076.
20. Wan Y, Chang HY: HOTAIR: flight of noncoding RNAs in cancer metastasis. Cell Cycle 2010; 9: 3391-3392.
21. -ΔΔCT method. Methods 2001; 25: 402-408.
22. Huarte M, Rinn JL: Large non-coding RNAs: missing links in cancer? Hum Mol Genet 2010; 19: R152-R161.
23. Ji P, Diederichs S, Wang W, et al: MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003; 22: 8031-8041.
24. Yang Z, Zhou L, Wu LM, et al: Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 2011; 18: 1243-1250.
25. Xiaohong S, Huikai L, Feng W, et al: Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma. World J Surg 2010; 34: 1028-1033.
26. Sun HC, Zhuang PY, Qin LX, et al: Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy. J Surg Oncol 2007; 96: 37-45.
27. Uenishi T, Hirohashi K, Shuto T, et al: The clinical significance of lymph node metastases in patients undergoing surgery for hepatocellular carcinoma. Surg Today 2000; 30: 892-895.
28. Yao FY, Ferrell L, Bass NM, et al: Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002; 8: 765-774.
29. Delis SG, Bakoyiannis A, Tassopoulos N, et al: Hepatic resection for large hepatocellular carcinoma in the era of UCSF criteria. HPB (Oxford) 2009; 11: 551-558.
30. Alsina AE: Liver transplantation for hepatocellular carcinoma. Cancer Control 2010; 17: 83-86.
31. Kim KJ, Li B, Winer J, et al: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993; 362: 841-844.
32. Li L, Zhang R, Fang ZY, et al: Suppression of vascular endothelial growth factor (VEGF) expression by targeting the Bcr-Abl oncogene and protein tyrosine kinase activity in Bcr-Abl-positive leukaemia cells. J Int Med Res 2009; 37: 426-437.
33. Lee LY, Wu CM, Wang CC, et al: Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression. Histol Histopathol 2008; 23: 515-521.
34. Maresh GA, Erezyilmaz D, Murry CE, et al; Detection and quantitation of perlecan mRNA levels in Alzheimer's disease and normal aged hippocampus by competitive reverse transcription-polymerase chain reaction. J Neurochem 1996; 67: 1132-1144.
35. Milas M, Shin J, Gupta M, et al: Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples. Ann Surg 2010; 252: 643-651.
36. Al Olaby RR, Azzazy HM: Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications. Expert Rev Mol Diagn 2011; 11: 53-64.
37. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
38. Bishop JA, Benjamin H, Cholakh H, et al: Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 2010; 16: 610-619.